(AR-PRO):

Peng Zhang1,2, Jiaming Ren1,2, Tao Chen3,4

  • 1Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.

概括

针对中国患者,开发了一种针对过敏性鼻炎的新型患者报告结果表 (AR-PRO). 这个20项级别表现出强大的可靠性和有效性,用于临床试验.